| Varun Mitroo, MD | |
|
1867 E Fir Ave, Suite 104, Fresno, CA 93720-3808 | |
| (559) 325-5800 | |
| Not Available |
| Full Name | Varun Mitroo |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 1867 E Fir Ave, Fresno, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336222025 | NPI | - | NPPES |
| 2634635 | Other | PA | AETNA |
| 132565 | Other | PA | BLUE SHIELD PA |
| 2018747000 | Other | PA | KEYSTONE HEALTHPLAN EAST |
| 0186159703 | Other | PA | AMERICHOICE |
| 0018615970001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD417151 (Pennsylvania) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | C52806 (California) | Primary |
| Entity Name | Ellis Bandt Birkin Kollins & Wong Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578584678 PECOS PAC ID: 4486568946 Enrollment ID: O20031118000697 |
News Archive
Clinical oncology pathways are an important tool, helping cancer care providers and their patients to zero in on the most appropriate care plan.
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
The Louisiana Tumor Registry (LTR) at the LSU Health Sciences Center New Orleans School of Public Health has been awarded a $12 million contract over seven years by the National Cancer Institute to continue its work as a SEER (Surveillance, Epidemiology and End Results) Program-designated cancer registry. There are 18 competitively awarded SEER cancer registries in the United States.
With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.
A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.
› Verified 8 days ago
| Entity Name | Southwest Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659346005 PECOS PAC ID: 6103730544 Enrollment ID: O20031118001102 |
News Archive
Clinical oncology pathways are an important tool, helping cancer care providers and their patients to zero in on the most appropriate care plan.
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
The Louisiana Tumor Registry (LTR) at the LSU Health Sciences Center New Orleans School of Public Health has been awarded a $12 million contract over seven years by the National Cancer Institute to continue its work as a SEER (Surveillance, Epidemiology and End Results) Program-designated cancer registry. There are 18 competitively awarded SEER cancer registries in the United States.
With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.
A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.
› Verified 8 days ago
| Entity Name | Optum Medical Group Ii Rhodes P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770556037 PECOS PAC ID: 4981687779 Enrollment ID: O20040611000770 |
News Archive
Clinical oncology pathways are an important tool, helping cancer care providers and their patients to zero in on the most appropriate care plan.
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
The Louisiana Tumor Registry (LTR) at the LSU Health Sciences Center New Orleans School of Public Health has been awarded a $12 million contract over seven years by the National Cancer Institute to continue its work as a SEER (Surveillance, Epidemiology and End Results) Program-designated cancer registry. There are 18 competitively awarded SEER cancer registries in the United States.
With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.
A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.
› Verified 8 days ago
| Entity Name | Shelin Agrawal And Hyer Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861783961 PECOS PAC ID: 5890955959 Enrollment ID: O20120327000625 |
News Archive
Clinical oncology pathways are an important tool, helping cancer care providers and their patients to zero in on the most appropriate care plan.
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
The Louisiana Tumor Registry (LTR) at the LSU Health Sciences Center New Orleans School of Public Health has been awarded a $12 million contract over seven years by the National Cancer Institute to continue its work as a SEER (Surveillance, Epidemiology and End Results) Program-designated cancer registry. There are 18 competitively awarded SEER cancer registries in the United States.
With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.
A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Varun Mitroo, MD 1867 E Fir Ave, Suite 104, Fresno, CA 93720-3808 Ph: (559) 325-5800 | Varun Mitroo, MD 1867 E Fir Ave, Suite 104, Fresno, CA 93720-3808 Ph: (559) 325-5800 |
News Archive
Clinical oncology pathways are an important tool, helping cancer care providers and their patients to zero in on the most appropriate care plan.
Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.
The Louisiana Tumor Registry (LTR) at the LSU Health Sciences Center New Orleans School of Public Health has been awarded a $12 million contract over seven years by the National Cancer Institute to continue its work as a SEER (Surveillance, Epidemiology and End Results) Program-designated cancer registry. There are 18 competitively awarded SEER cancer registries in the United States.
With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.
A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.
› Verified 8 days ago
David Toshio Nakamura, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 6107 N Fresno St, Fresno, CA 93710 Phone: 858-703-7272 | |
Dr. William J Vlymen, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1243 E Spruce, Ste 101, Fresno, CA 93720 Phone: 559-439-7226 | |
Dr. Judy L. Champaign, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 6297 N Fresno St, Fresno, CA 93710 Phone: 559-325-5876 | |
Dr. Ivan Ramirez, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1867 E Fir Ave, Suite 104, Fresno, CA 93720 Phone: 559-325-5800 Fax: 559-325-5838 | |
Dr. Puneet Rana, MD, MS Radiology Medicare: Medicare Enrolled Practice Location: 1827 E Fir Ave Ste 101, Fresno, CA 93720 Phone: 559-400-7629 | |
Michael Edward Cody, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 7300 N Fresno St, Fresno, CA 93720 Phone: 559-448-4500 | |
Shushan Petrosyan, RDCS, RDMS, RVT Radiology Medicare: Not Enrolled in Medicare Practice Location: 1095 E Shaw Ave Ste 200a, Fresno, CA 93710 Phone: 559-906-6667 |